Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
Coming Soon – October 2019
More than two dozen antiepileptic drugs (AEDs) are available in the United States, yet approximately one-third of epilepsy patients are refractory to AED treatment. Opportunity in this arena has spurred the development of a range of new AEDs targeting drug-resistant epilepsy, particularly highly refractory orphan pediatric subpopulations such as Lennox-Gastaut syndrome, Dravet syndrome, and patients with acute repetitive seizures; nine AEDs have been recently approved or are in late-phase development for these and other clinical niches. Understanding how prescribers perceive and plan to incorporate new brands is critical for developers facing a complicated, highly generic, and increasingly competitive market.
Geographies: United States
Primary research: Survey of 100 neurologists
Key drugs covered: Epidiolex, Fintepla, cenobamate, padsevonil, Libervant, Nayzilam, Valtoco
Key insights provided:
DRG’s Special Topics reports use quantitative primary research to assess evolving trends and market effects in dynamic disease areas. Insights from this report on epilepsy will help developers gauge the competitiveness of their late-phase pipeline candidates and design messages to support or defend their market position.
Already a Client? Log in to access this report.
Bethany Christmann, has been with DRG since 2015, and is a Senior Business Insights Analyst with the Central Nervous System/Ophthalmology team. In this role, she covers the neurology space, specializing in Parkinson’s disease and epilepsy; she provides expert insight and authors primary market research and forecasting content focused on these and other neurology indications. Prior to joining DRG, Bethany earned her in neuroscience from Brandeis University, where she studied the cellular interactions involved in memory consolidation and their link to sleep behavior.